Related Experiment Video
Updated: Feb 5, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific
Tom Parke1, Vladimir Dragalin2, Ibrahim Turkoz3
11 Tessella Ltd, Oxfordshire, UK.
Abstract:
The International Society for CNS Clinical Trials and Methodology (ISCTM) Adaptive Design Working Group (IADWG) designed a case study simulation exercise to compare the value of traditional versus adaptive design approaches to phase II clinical trial design in schizophrenia in statistical and economic terms. Operational characteristics of both designs were compared across 7 likely dose-response curves. Based on IADWG members' recent research experience in schizophrenia, estimates of expected net present value (eNPV) for the molecule were compared for the traditional and adaptive designs. Across dose-response curve scenarios with a minimum effective dose (MED), the adaptive design was more likely to show proof of concept and correctly identify the MED than was the traditional design. Even with a conservative weighting of possible dose-response curves, using an adaptive design in phase II resulted in higher eNPV. This simulation supports the statistical and economic value for decision makers exploring the use of adaptive approaches to phase II research in schizophrenia.
More Related Videos
Related Concept Videos
The Scientific Method
The Scientific Method
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
The Scientific Method
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Schizophrenia

